CYAD logo

Celyad Oncology SA (CYAD) Free Cash Flow

Annual FCF

-$29.67 M
+$2.32 M+7.25%

December 31, 2022

Summary

Performance

1-Year Change

+7.25%

3-Year Change

+8.06%

5-Year Change

+42.17%

15-Year Change

+42.17%

CYAD Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$11.56 M

3-Year Low

-$31.99 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CYAD previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CYAD next annual earnings announcement has not yet been scheduled

OtherCYADcash flowmetrics:

Annual CFO

-$29.54 M
CYAD annual cash flow from operations is -$29.54 million

Annual CFF

$3.42 M
CYAD annual cash flow from financing activities is $3.42 million

Annual CFI

$7.60 M
CYAD annual cash flow from investing activities is $7.60 million

Annual CAPEX

-
CYAD annual capital expenditures value is unknown

Quarterly FCF

-$17.48 M
NaN%

June 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-16.93%

3-Year Change

-

5-Year Change

-

CYAD Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$14.95 M

3-Year Low

-$17.48 M
CYAD quarterly free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CYAD previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CYAD next earnings announcement has not yet been scheduled

OtherCYADcash flowmetrics:

Quarterly CFO

-$17.37 M
CYAD quarterly cash flow from operations is -$17.37 million

Quarterly CFF

-$474.00 K
CYAD quarterly cash flow from financing activities is -$474.00 thousand

Quarterly CFI

$1.21 M
CYAD quarterly cash flow from investing activities is $1.21 million

Quarterly CAPEX

-
CYAD quarterly capital expenditures value is unknown

TTM FCF

-$17.48 M
NaN%

June 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-16.93%

3-Year Change

-

5-Year Change

-

CYAD TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$14.95 M

3-Year Low

-$17.48 M
CYAD TTM free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CYAD previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CYAD next earnings announcement has not yet been scheduled

OtherCYADcash flowmetrics:

TTM CFO

-$17.37 M
CYAD TTM cash flow from operations is -$17.37 million

TTM CFF

-$474.00 K
CYAD TTM cash flow from financing activities is -$474.00 thousand

TTM CFI

$1.21 M
CYAD TTM cash flow from investing activities is $1.21 million

TTM CAPEX

-
CYAD TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$29.67 M
CYAD annual free cash flow is -$29.67 million

Annual CFO

-$29.54 M
CYAD annual cash flow from operations is -$29.54 million

Annual CAPEX

-
CYAD annual capital expenditures value is unknown

CYAD Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.3%-16.9%-16.9%
3 y3 years+8.1%--
5 y5 years+42.2%--

CYAD Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.8%at highat lowat highat low
5 y5-yearat high+8.8%+16.9%at low+16.9%at low
alltimeall time+156.6%+72.9%+16.9%at low+16.9%at low

Celyad Oncology SA Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2022
-$29.67 M(-7.3%)
-
-
Jun 2022
-
-$17.48 M(+16.9%)
-$17.48 M(+16.9%)
Dec 2021
-$31.99 M(+0.1%)
-
-
Jun 2021
-
-$14.95 M
-$14.95 M
Dec 2020
-$31.96 M(-1.0%)
-
-
Dec 2019
-$32.27 M(-5.8%)
-
-
DateAnnualQuarterlyTTM
Dec 2018
-$34.26 M(-33.2%)
-
-
Dec 2017
-$51.30 M(+75.1%)
-
-
Dec 2016
-$29.30 M(-6.2%)
-
-
Dec 2015
-$31.23 M(+30.1%)
-
-
Dec 2014
-$24.01 M(+61.8%)
-
-
Dec 2013
-$14.83 M(+28.3%)
-
-
Dec 2012
-$11.56 M
-
-

FAQ

  • What is Celyad Oncology SA annual free cash flow?
  • What is the all time high annual FCF for Celyad Oncology SA?
  • What is Celyad Oncology SA annual FCF year-on-year change?
  • What is Celyad Oncology SA quarterly free cash flow?
  • What is the all time high quarterly FCF for Celyad Oncology SA?
  • What is Celyad Oncology SA quarterly FCF year-on-year change?
  • What is Celyad Oncology SA TTM free cash flow?
  • What is the all time high TTM FCF for Celyad Oncology SA?
  • What is Celyad Oncology SA TTM FCF year-on-year change?

What is Celyad Oncology SA annual free cash flow?

The current annual FCF of CYAD is -$29.67 M

What is the all time high annual FCF for Celyad Oncology SA?

Celyad Oncology SA all-time high annual free cash flow is -$11.56 M

What is Celyad Oncology SA annual FCF year-on-year change?

Over the past year, CYAD annual free cash flow has changed by +$2.32 M (+7.25%)

What is Celyad Oncology SA quarterly free cash flow?

The current quarterly FCF of CYAD is -$17.48 M

What is the all time high quarterly FCF for Celyad Oncology SA?

Celyad Oncology SA all-time high quarterly free cash flow is -$14.95 M

What is Celyad Oncology SA quarterly FCF year-on-year change?

Over the past year, CYAD quarterly free cash flow has changed by -$2.53 M (-16.93%)

What is Celyad Oncology SA TTM free cash flow?

The current TTM FCF of CYAD is -$17.48 M

What is the all time high TTM FCF for Celyad Oncology SA?

Celyad Oncology SA all-time high TTM free cash flow is -$14.95 M

What is Celyad Oncology SA TTM FCF year-on-year change?

Over the past year, CYAD TTM free cash flow has changed by -$2.53 M (-16.93%)